MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/jtd-2026-1197

Медицинская библиотека · Journal of thoracic disease · 2026

Clinical diagnosis and treatment of eosinophilic asthma by respiratory physicians in China: a cross-sectional survey.

Deng Yongling, Kong Xuetao, Chen Yan, Jiang Mei, Yu Lin, Xie Jiaxing

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Eosinophilic asthma (EA) differs from allergic asthma (AA) by later onset, higher exacerbation risk, rapid progression, pronounced airway limitation, and increased comorbidities. However, understanding of asthma phenotypes, particularly EA, remains inadequate among physicians, posing diagnostic and therapeutic challenges. This study aims to investigate the current understanding, diagnostic approaches, and treatment practices for EA among respiratory physicians in China.

METHODS

This cross-sectional study was conducted in the Chinese mainland from January to March 2024. A structured electronic questionnaire, developed and verified by a multidisciplinary panel from the Department of Pulmonary and Critical Care Medicine at The First Affiliated Hospital of Guangzhou Medical University and related specialties, was utilized to assess respiratory physicians' clinical attention, diagnostic-therapeutic practices, and depth of knowledge concerning EA.

RESULTS

Of the 572 valid responses, 51.0% of respiratory physicians consistently emphasized eosinophil levels in complete blood counts during asthma assessments. While a majority of physicians demonstrated awareness of key EA characteristics, their clinical practices revealed significant gaps and inconsistencies. Only 4.4% of physicians routinely performed phenotypic analysis on diagnosed asthma patients. In the selection of biologic targeted therapy for EA, omalizumab was the most preferred choice (60.1% of respondents), followed by mepolizumab (35.7%) and benralizumab (16.4%). Notably, 92.3% of surveyed physicians agreed that China requires national diagnostic and management guidelines/consensus for EA.

CONCLUSIONS

Respiratory physicians in China demonstrate inconsistent knowledge and practice regarding EA, with gaps in phenotyping, eosinophil monitoring, comorbidity attention, and targeted therapy selection. The strong consensus for guideline development highlights the need for standardized protocols to bridge these gaps.

Для цитирования: Deng Yongling, Kong Xuetao, Chen Yan, Jiang Mei, Yu Lin, Xie Jiaxing. Clinical diagnosis and treatment of eosinophilic asthma by respiratory physicians in China: a cross-sectional survey.. Journal of thoracic disease. 2026. DOI: 10.21037/jtd-2026-1197.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.